Articles

Find an Article

Filter articles

Applied Filters

Showing 11 to 20 of 256 results

Generic competition: when one door closes, another opens

EU, US26-10-2018

With several major drugs set to face generic or biosimilar competition as patent protection expires, LSIPR analyses how well prepared their manufacturers are and how badly their sales may be affected.

The future of precision medicine part 3: translation from research to the clinic

UK, US23-10-2018Daniel Lim

The implementation of precision medicine represents a huge, possibly unprecedented, challenge to conventional clinical practice across the breadth of healthcare disciplines, says Daniel Lim of Kirkland & Ellis.

Gene-editing: a block on further development

EU22-10-2018

An EU court ruling on gene-editing regulation has sparked widespread concerns in the scientific and legal communities, as LSIPR finds out.

SPC waiver: good intentions, but not the right deal?

EU17-10-2018

The European Commission’s proposed export waiver for supplementary protection certificates has exposed a number of likely flaws which have not gone down well with patent owners. LSIPR reports.

How the EPO treats personalised healthcare patents

EU12-10-2018Laurence Gainey

The patenting of personalised healthcare inventions has proved problematic in a 
number of jurisdictions, but various aspects of these inventions are patentable in Europe, as Laurence Gainey of HGF explains.

Arrow declarations: which way is the law pointing?

UK08-10-2018David Holt and Tony Proctor

Depending on the facts and the content of the applications, an Arrow-type declaration could be made on grounds of insufficiency against divisional applications, say David Holt and Tony Proctor of Potter Clarkson.

Conference preview: BIO-Europe 2018

Denmark02-10-2018

BIO-Europe heads to Scandinavia for the first time, as Copenhagen plays host in November. LSIPR finds out more.

CRISPR patents: guidance from US courts

US19-09-2018Pat Carson and Mira Atanassova Mulvaney

Several recent cases from the US Court of Appeals for the Federal Circuit offer guidance on navigating the §101 legal framework with respect to CRISPR patent claims, as Pat Carson and Mira Atanassova Mulvaney of Kirkland & Ellis report.

Boehringer v Teva: Italian court clarifies boundaries of Bolar privilege

Italy11-09-2018Gabriel Cuonzo and Luca Pellicciari

The Milan Court has issued an important ruling clarifying the rules governing the activities of active pharmaceutical ingredient manufacturers in Italy, as Gabriel Cuonzo and Luca Pellicciari of Trevisan & Cuonzo report.

LSIPR 50 2018: Frank Kalkbrenner

Germany28-08-2018

Frank Kalkbrenner was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the investment section, as LSIPR reports.

Showing 11 to 20 of 256 results

LSIPR